- Drugs
- Feeding Tubes
- Nutritional Solutions
Dysphagia Management Market was valued at USD 726.5 million in 2022 and is poised to grow at a significant CAGR of 12.9% over 2023-2029. Dysphagia is becoming more common as the prevalence of various malignancies, particularly oral cancer, rises. Furthermore, some cancer treatments can create swallowing problems as a side effect, necessitating the usage of an appropriate dysphagia supplement to avoid further complications. Dysphagia is more common in persons who have Parkinson's disease or stroke. One of the most severe adverse effects of smoking cigarettes for an extended period is dysphagia. While smoking tobacco kills around 6 million people each year, the dysphagia management market is progressively growing due to the increased frequency of oropharyngeal malignancies. Because of the devastating consequences of choking, dysphagia management has become critical in geriatric and juvenile populations. Proton pump inhibitors, feeding tubes, and nutritional treatments such as thickeners and beverages are some alternatives for dysphagia management. The appropriate dysphagia management option is determined by the severity of the condition.
According to the World Heart Association, 15 million people have a stroke each year, with 6 million dying and 6 million becoming disabled, resulting in eyesight loss and speech impairment.As a result, the rising prevalence of stroke-related dysphagia and associated pharyngeal and laryngeal problems is propelling the dysphagia management market forward. Market players can concentrate on launching over-the-counter medications to treat dysphagia. For example, most Western European pharmaceutical corporations, such as Bayer AG and Johnson & Johnson, are expanding into the OTC market as a contiguous out-of-pocket sector. Moreover, the market is likely to benefit from establishing standard definitions of dysphagia and malnutrition, an in-depth analysis of the link between causes and outcomes of dysphagia and emphasizing the significance of efficient and accurate screening. One of the most essential methods used by prominent market players in the dysphagia management landscape is to focus their efforts on acquiring smaller players in the dysphagia market. Furthermore, they are likely to focus on company expansion in the dysphagia management field outside of their major geographic markets.
Study Period
2024-2030Base Year
2023CAGR
12.9%Largest Market
Asia PacificFastest Growing Market
North America
The rising number of people addicted to smoking is expected to impact the dysphagia market's growth. Dysphagia is one of the most dangerous side effects of smoking cigarettes for a lengthy period. While tobacco usage kills nearly 6 million people each year, the rising prevalence of oropharyngeal cancer drives the dysphagia market forward. The market's expansion is projected to be restrained by the side effects and pain of dysphagia medications and tubes. Long-term use of dysphagia medicines like proton pump inhibitors is linked to a higher risk of hip fracture due to decreased calcium and iron absorption, as well as an increased risk of opportunistic infections with S. pneumoniae and C. difficult due to weakened natural gut flora.
By Product Type
By Indication Type
By Distribution Channel
The dysphagia management market is projected to expand at a CAGR of 12.9% during the forecast period
Eisai Co. Ltd., Becton, Dickinson and Company (BD), AstraZeneca Plc., Cipla Limited, Nestlé (Nestlé Health Science)
North America is the fastest-growing region for dysphagia management market
1. Executive Summary |
2. Global Dysphagia Management Market Introduction |
2.1. Global Dysphagia Management Market - Taxonomy |
2.2. Global Dysphagia Management Market - Definitions |
2.2.1. By Product Type |
2.2.2. By Indication |
2.2.3. By Distribution Channel |
2.2.4. By Region |
3. Global Dysphagia Management Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Key Developments |
4. Global Dysphagia Management Market By Product Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
4.1. Drugs |
4.1.1. Proton Pump Inhibitors |
4.1.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
4.1.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
4.1.1.3. Market Opportunity Analysis |
4.2. Feeding Tubes |
4.2.1. Naso-Gastric Tubes and |
4.2.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
4.2.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
4.2.1.3. Market Opportunity Analysis |
4.2.2. PEG Tubes |
4.2.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
4.2.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
4.2.2.3. Market Opportunity Analysis |
4.3. Nutritional Solutions |
4.3.1. Thickeners, |
4.3.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
4.3.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
4.3.1.3. Market Opportunity Analysis |
4.3.2. Beverages, and |
4.3.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
4.3.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3.2.3. Market Opportunity Analysis |
4.3.3. Puree |
4.3.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
4.3.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3.3.3. Market Opportunity Analysis |
5. Global Dysphagia Management Market By Indication, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
5.1. Oropharyngeal Dysphagia |
5 1 1 Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Esophageal Dysphagia |
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Others |
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
6. Global Dysphagia Management Market By Distribution Channel, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
6.1. Hospital Pharmacies |
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Retail Pharmacies |
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Drug Stores |
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Speciality Clinics |
6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Others |
6.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
7. Global Dysphagia Management Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
7.1. North America |
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Europe |
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Asia Pacific |
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Latin America |
7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. MEA |
7.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
8. North America Dysphagia Management Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
8.1. Product Type Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.1.1. Drugs |
8.1.1.1. Proton Pump Inhibitors |
8.1.2. Feeding Tubes |
8.1.2.1. Naso-Gastric Tubes and |
8.1.2.2. PEG Tubes |
8.1.3. Nutritional Solutions |
8.1.3.1. Thickeners, |
8.1.3.2. Beverages, and |
8.1.3.3. Puree |
8.2. Indication Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.2.1. Oropharyngeal Dysphagia |
8.2.2. Esophageal Dysphagia |
8.2.3. Others |
8.3. Distribution Channel Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.3.1. Hospital Pharmacies |
8.3.2. Retail Pharmacies |
8.3.3. Drug Stores |
8.3.4. Speciality Clinics |
8.3.5. Others |
8.4. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.4.1. USA |
8.4.2. Canada |
9. Europe Dysphagia Management Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
9.1. Product Type Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1. Drugs |
9.1.1.1. Proton Pump Inhibitors |
9.1.2. Feeding Tubes |
9.1.2.1. Naso-Gastric Tubes and |
9.1.2.2. PEG Tubes |
9.1.3. Nutritional Solutions |
9.1.3.1. Thickeners, |
9.1.3.2. Beverages, and |
9.1.3.3. Puree |
9.2. Indication Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1. Oropharyngeal Dysphagia |
9.2.2. Esophageal Dysphagia |
9.2.3. Others |
9.3. Distribution Channel Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1. Hospital Pharmacies |
9.3.2. Retail Pharmacies |
9.3.3. Drug Stores |
9.3.4. Speciality Clinics |
9.3.5. Others |
9.4. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1. Germany |
9.4.2. France |
9.4.3. Italy |
9.4.4. Spain |
9.4.5. UK |
9.4.6. Rest of Europe |
10. Asia Pacific Dysphagia Management Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
10.1. Product Type Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1. Drugs |
10.1.1.1. Proton Pump Inhibitors |
10.1.2. Feeding Tubes |
10.1.2.1. Naso-Gastric Tubes and |
10.1.2.2. PEG Tubes |
10.1.3. Nutritional Solutions |
10.1.3.1. Thickeners, |
10.1.3.2. Beverages, and |
10.1.3.3. Puree |
10.2. Indication Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1. Oropharyngeal Dysphagia |
10.2.2. Esophageal Dysphagia |
10.2.3. Others |
10.3. Distribution Channel Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1. Hospital Pharmacies |
10.3.2. Retail Pharmacies |
10.3.3. Drug Stores |
10.3.4. Speciality Clinics |
10.3.5. Others |
10.4. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1. China |
10.4.2. Japan |
10.4.3. South Korea |
10.4.4. India |
10.4.5. Rest of APAC |
11. Latin America Dysphagia Management Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
11.1. Product Type Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Drugs |
11.1.1.1. Proton Pump Inhibitors |
11.1.2. Feeding Tubes |
11.1.2.1. Naso-Gastric Tubes and |
11.1.2.2. PEG Tubes |
11.1.3. Nutritional Solutions |
11.1.3.1. Thickeners, |
11.1.3.2. Beverages, and |
11.1.3.3. Puree |
11.2. Indication Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1. Oropharyngeal Dysphagia |
11.2.2. Esophageal Dysphagia |
11.2.3. Others |
11.3. Distribution Channel Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1. Hospital Pharmacies |
11.3.2. Retail Pharmacies |
11.3.3. Drug Stores |
11.3.4. Speciality Clinics |
11.3.5. Others |
11.4. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1. Brazil |
11.4.2. Mexico |
11.4.3. Argentina |
11.4.4. Rest of Latin America |
12. MEA Dysphagia Management Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
12.1. Product Type Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1. Drugs |
12.1.1.1. Proton Pump Inhibitors |
12.1.2. Feeding Tubes |
12.1.2.1. Naso-Gastric Tubes and |
12.1.2.2. PEG Tubes |
12.1.3. Nutritional Solutions |
12.1.3.1. Thickeners, |
12.1.3.2. Beverages, and |
12.1.3.3. Puree |
12.2. Indication Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1. Oropharyngeal Dysphagia |
12.2.2. Esophageal Dysphagia |
12.2.3. Others |
12.3. Distribution Channel Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1. Hospital Pharmacies |
12.3.2. Retail Pharmacies |
12.3.3. Drug Stores |
12.3.4. Speciality Clinics |
12.3.5. Others |
12.4. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1. GCC Countries |
12.4.2. South Africa |
12.4.3. Rest of MEA |
13. Competition Landscape |
13.1. Strategic Dashboard of Top Market Players |
13.2. Company Profiles (Introduction, Financial Analysis, By Product Offerings, Key Developments, Strategies, and SWOT Analysis) |
13.2.1. Eisai Co. Ltd. |
13.2.2. Becton |
13.2.3. Dickinson and Company (BD) |
13.2.4. AstraZeneca Plc. |
13.2.5. Cipla Limited |
13.2.6. Nestlé (Nestlé Health Science) |
13.2.7. Kent Corporation |
13.2.8. Danone |
13.2.9. Cook Group |
14. Research Methodology |
15. Key Assumptions and Acronyms |